[1]
|
De Geest, S., Borgermans, L., Gemoets, H., Abraham, I., Vlaminck, H., Evers, G., et al. (1995) Incidence, Determinants, and Consequences of Subclinical Noncompliance with Immunosuppressive Therapy in Renal Transplant Recipients. Transplantation, 59, 340-347. http://dx.doi.org/10.1097/00007890-199502000-00006
|
[2]
|
Butler, J.A., Roderick, P., Mullee, M., Mason, J.C. and Peveler, R.C. (2004) Frequency and Impact of Nonadherence to Immunosuppressants after Renal Transplantation: A Systematic Review. Transplantation, 77, 769-776. http://dx.doi.org/10.1097/01.TP.0000110408.83054.88
|
[3]
|
Ichimaru, N., Kakuta, Y., Abe, T., Okumi, M., Imamura, R., Isaka, Y., et al. (2008) Treatment Adherence in Renal Transplant Recipients: A Questionnaire Survey on Immunosuppressants. Transplantation Proceedings, 40, 1362-1365. http://dx.doi.org/10.1016/j.transproceed.2008.02.083
|
[4]
|
Obi, Y., Ichimaru, N., Kato, T., Kaimori, J.Y., Okumi, M., Yazawa, K., et al. (2013) A Single Daily Dose Enhances the Adherence to Immunosuppressive Treatment in Kidney Transplant Recipients: A Cross-Sectional Study. Clinical and Experimental Nephrology, 17, 310-315. http://dx.doi.org/10.1007/s10157-012-0713-4
|
[5]
|
Bullingham, R., Monroe, S., Nicholls, A. and Hale, M. (1996) Pharmacokinetics and Bioavailability of Mycophenolate Mofetil in Healthy Subjects after Single-Dose Oral and Intravenous Administration. The Journal of Clinical Pharmacology, 36, 315-324. http://dx.doi.org/10.1002/j.1552-4604.1996.tb04207.x
|